focus -WSS

focus

author：hotspot 2025-09-28 23:48:07 - browse：532

SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and reviewed by STAT.

The layoffs, which began last Wednesday, impact research teams across the company’s California sites in San Diego and Foster City, as well as locations in Madison, Wisconsin; Singapore; and the United Kingdom. Alex Aravanis, the company’s chief technology officer, noted in an internal message that these cuts affect a tenth of research and development staff. The company’s also planning to shut down all lab-based research and development work in Foster City, according to a note from Steve Barnard, vice president of technology development.

Barnard’s note mentions that all affected employees have already been notified. And a separate message from interim CEO Charles Dadswell makes clear last week’s layoffs won’t be the last.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： How Brent Saunders' Allergan experiment failed

hotspot

WSS

Trump Organization, Michael Cohen agree to settle million

'Null' research findings aren't empty of meaning. Let's publish them

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Chris Christie meets with Zelenskyy during Ukraine trip

Medicare slashes safety net hospital payments by nearly $1 billion

How to ethically and practically extend health care to all

Wikipedia

focus

explore

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

What is the Turing Test that determines if computers can think?

Hepatitis C has a cure — but many Americans still lack access to it

Pharma showers House GOP doctor with campaign cash

Novavax promises a turnaround & Lilly roils the obesity market

Flint parents haunted by uncertainty, fears of lead poisoning

Virginia high school admissions case could be legal follow

Alnylam reports growth in sales of rare disease treatments

Peter Hotez and the public health issue of online harassment

Group behind ProMed defends move to subscription

leisure time

Alnylam reports growth in sales of rare disease treatments

When waiting feels immoral: Empathy in the emergency department

FDA approves Sage Therapeutics’ rapid

What is artificial intelligence? Experts weigh in

Florida officials tell state schools to teach AP Psychology 'in its entirety'

What is artificial intelligence? Experts weigh in

hotspot

hotspot

hotspot

focus